''Integrated DNA Technologies (IDT)...today announced the launch of Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx in vitro diagnostic (IVD) offerings. This milestone marks IDT’s strategic entry into the next generation sequencing (NGS) IVD market, reinforcing its commitment to quality, regulatory compliance, and clinical impact. By introducing IVD-grade solutions in the US and select European countries, IDT is filling a market gap for standardized workflows in oncology diagnostics.''